1 王露楠,吴健民.丙型肝炎病毒核酸检测的国家标准物质的研制[J].中华检验医学杂,2006,29(4):354~357. 2 叶子弘,赵煦泓,邹克琴,等.生物标准物质研究简析[J].化学计量与分析技术,2009,4:67~69. 3 吴亚琼,高志强,吴延功,等.亚洲Ⅰ型口蹄疫病毒核酸检测标准物质的制备研究[J].中国兽医杂志,2012,48(8):8~12. 4 张洁.生物标准物质的制备、发展及管理[J].中国生物制品学杂志,2007,20(8):630~632. 5 张桂山,徐晶,娄玉杰,等.小尾寒羊瘦素长型受体基因实时荧光定量PCR标准品质粒和标准曲线的构建[J].中国畜牧兽医,2014,41(3):111~114. 6 谷强,张伟,高志强,等.新城疫病毒核酸检测标准物质研究[J].中国动物检疫,2012,29(11):40~43. 7 俞晓平,叶子弘,蒋家新,等.生物计量及其在检验检疫中的应用研究[J]. 中国计量学院学报,2008,19(4):289~295. 8 高尚,先黄杰.体外诊断试剂标准物质国内外现状[J].药物分析杂志,2008,7:81~87. 9 Holmes H, Davis C, Heath A, et al.An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques[J].J Virol Methods, 2001, 92(2): 141~150. 10 Holmes H, Davis C, Heath A. Development of the 1st international reference panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques[J]. J Virol Methods, 2008, 154(1~2): 86~91. 11 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays,BS10.2138[S].Geneva, World Health Organization, 2010. 12 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 4th WHO international standard for hepatitis C virus (HCV) for nucleic acid amplification technology (NAT)-based assays,BS2011.2173[S].Geneva,World Health Organization,2011a. 13 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 3rd WHO international standard for hepatitis B virus (HBV) for nucleic acid amplification technology (NAT)-based assays,BS2011.2170[S]. Geneva, World Health Organization, 2011b. 14 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 1st WHO international standard for Epstein-Barr virus (EBV) for nucleic acid amplification technology (NAT)-based assays,BS2011.2172[S]. Geneva,World Health Organization, 2011c. 15 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 3rd WHO international standard for parvovirus B19 (B19V) for nucleic acid amplification technology (NAT)-based assays,BS2013.2224[S]. Geneva,World Health Organization, 2013a. 16 Jacqueline F F, Alan B H, Dianna E W, et al. Collaborative study to evaluate the proposed 2nd WHO international standard for hepatitis A virus (HAV) for nucleic acid amplification technology (NAT)-based assays,BS2013.2225[S]. Geneva, World Health Organization, 2013b. 17 Madej R M, Davis J, Holden M J, et al. International standards and reference materials for quantitative molecular infectious disease testing[J].J Mol Diagn, 2010, 12(2): 133~143. 18 Michael C, Kay-Martin H, Julia K, et al. Collaborative study to establish a World Health Organization international genotype panel for hepatitis B virus nucleic acid amplification technique (NAT)-based assays,BS09.2121[S].Geneva,World Health Organization, 2009. 19 Michael C, Kay-Martin H, Mithat B, et al. Collaborative study to establish a World Health Organization international standard for hepatitis D virus RNA for nucleic acid amplification technique (NAT)-based assays, BS2013.2227[S]. Geneva, World Health Organization, 2013. 20 Morris C L, Heath A B. International collaborative study to establish the 3rd WHO international standard for HIV-1 NAT assays, BS2011.2178[S]. Geneva, World Health Organization, 2011. 21 Morris C L, Wigglesworth E, Heath A B.Report on an international collaborative study to establish the 1st WHO international reference panel for HIV-1 circulating recombinant forms for NAT assays, BS2013.2226[S].Geneva, World Health Organization, 2013. 22 Padley D J, Heath A B, Sutherland C, et al. Establishment of the 1st World Health Organization international standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays[J]. Malar J, 2008, 7: 139. 23 Saldanha J, Leli N, Heath A, et al. Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA[J].Vox Sang, 1999, 76(3): 149~158. 24 Saldanha J, Gerlich W, Lelie N, et al.An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques[J].Vox Sang, 2001, 80(1): 63~71. 25 Saldanha J, Lelie N, Yu M W, et al. Establishment of the first World Health Organization international standard for human parvovirus B19 DNA nucleic acid amplification techniques[J].Vox Sang, 2002, 82(1): 24~31. 26 Saldanha J, Heath A, Lelie N, et al. A World Health Organization international standard for hepatitis A virus RNA nucleic acid amplification technology assays[J].Vox Sang, 2005, 89(1): 52~58. 27 Sally A B, Saeko M, Yoshiaki O, et al. Collaborative study to establish a World Health Organization international standard for hepatitis E virus RNA for nucleic acid amplification technique (NAT)-based assays,BS2011.2175[S]. Geneva, World Health Organization, 2011. 28 Wilkinson D E, Baylis S A, Padley D, et al. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA[J].Int J Cancer, 2010, 126(12): 2969~2983. 29 Yang Y C, Yang-Chih S D, Tsai M H, et al. A collaborative study to establish the first national standard for HIV-1 RNA nucleic acid amplification techniques (NAT) in Taiwan[J]. J Virol Methods, 2013, 191(2): 122~127. |